BioCentury
ARTICLE | Company News

Management tracks: Aeterna, Microbix, Dimension

July 31, 2017 11:02 PM UTC

Cancer and endocrinology company Aeterna Zentaris Inc. (TSX:AEZS; NASDAQ:AEZS) named Michael Ward CEO. He was chief compliance and legal officer and corporate secretary of Sagent Pharmaceuticals Inc., which Nichi-Iko Pharmaceutical Co. Ltd. (Tokyo:4541) acquired.

Diagnostics company Microbix Biosystems Inc. (TSX:MBX) named Cameron Groome president and CEO. Groome is also a director. He succeeds Vaughn Embro-Pantalony, who is retiring but will remain a director...